[Osteoporosis medications. Bisphosphonates exceed the others].
D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density; D018849:Controlled Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D010919:Placebos; D012307:Risk Factors
D004164:Diphosphonates; D010919:Placebos; D019386:Alendronate